在使用残余二极合的原生α-synuclein中定义远程顺序和局部障碍
Pau Bernadó1, Carlos W Bertoncini, Christian Griesinger
1Institute de Biologie Structurale Jean-Pierre Ebel, CNRS-CEA-UJF, 41 rue Jules Horowitz, 38027-Grenoble Cedex, France.
Journal of the American Chemical Society
|December 22, 2005
概括
这项研究揭示了剩余二极合 (RDC) 如何检测内在非结构化蛋白质的远程结构秩序. 这一突破有助于理解与帕金森病相关的α-Synuclein等蛋白质.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 生物物理学的生物物理.
背景情况:
- 本质非结构蛋白 (IUP) 在生物过程和疾病中至关重要.
- 研究IUP需要了解它们的动态,整体性质.
- 剩余二极合 (RDCs) 对毫秒时间尺度上的蛋白质动态敏感.
研究的目的:
- 为展开的蛋白质开发RDC的新解释.
- 在IUP中同时定义远程结构顺序和局部构造性采样.
- 描述alpha-Synuclein (alphaS) 的结构和动态,这是一种涉及帕金森病的蛋白质.
主要方法:
- 利用了对剩余二极合 (RDC) 的新解释.
- 应用RDC分析来研究α-Synuclein (alphaS) 的结构和动态.
- 开发了一个结构模型,结合了局部形状波动和远距离接触.
主要成果:
- 证明RDC可以同时报告长距离订单和在未折叠蛋白质中进行本地采样.
- 在alphaS.中毫不含糊地检测到有远距离接触的人口符合性动物.
- 显示了本地波动和远距离接触对于描述alphaS RDCs至关重要.
结论:
- 新的RDC解释为IUP的结构格局提供了新的见解.
- 这种方法揭示了高度灵活的系统中的远程秩序,以前没有被检测到.
- 增强对alphaS结构和动态的理解,与帕金森病相关.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


